E. Van Braeckel (Ghent, Belgium), L. Sander (Berlin, Germany)
This session is built from abstracts published on the ERS Congress platform from 23 August, in an e-poster pdf format with a 3-minute audio narration. Participants and chairs of the session are invited to access all e-posters from 23 August to 4 September prior to the 1-hour live, online discussion scheduled from September 5-7. Please note that during live discussion there will be NO e-poster/abstract presentations, only discussion.
Correlation between chest CT severity scores and clinical and biochemical parameters of COVID-19 pneumonia.
B. Kömürcüoglu (Izmir, Turkey), B. Ozgur (Izmir, Turkey), S. Bilge (Izmir, Turkey), S. Seher (Izmir, Turkey), K. Gulistan (Izmir, Turkey)
|   |
Liver dysfunction on admission worsen clinical manifestations and outcomes of Coronavirus Disease 2019
F. Lu (Shanghai, China), R. Chen (Shanghai, China), K. Xu (Shanghai, China), J. Huang (Shanghai, China), D. Yang (Anhui, China), T. Bai (Wuhan, China), Y. Feng (Wuhan, China), Y. Guo (Wuhan, China)
| |
Relationship between chest CT findings and clinical conditions of COVID-19: A multicentre experience
N. Yilmaz Demirci (Ankara, Turkey), A. Ugras Dikmen (Ankara, Turkey), C. Tasçi (Ankara, Turkey), D. Dogan (Ankara, Turkey), Y. Arslan (Ankara, Turkey), N. Öcal (Ankara, Turkey), M. Tasar (Ankara, Turkey), U. Bozlar (Ankara, Turkey), C. Artuk (Ankara, Turkey), G. Gülden (Ankara, Turkey), Z. Karacaer (Ankara, Turkey), I. Avci (Ankara, Turkey), G. Tuncer Ertem (Ankara, Turkey), F. Erdinç (Ankara, Turkey), S. Kinikli (Ankara, Turkey), S. Altun Demircan (Ankara, Turkey), E. Ergün (Ankara, Turkey), P. Kosar (Ankara, Turkey), A. Karakoç (Ankara, Turkey), A. Gökçek (Ankara, Turkey), M. Aloglu (Ankara, Turkey), S. Gülgösteren (Ankara, Turkey), S. Atikcan (Ankara, Turkey), S. Akçay (Ankara, Turkey), Ç. Erol (Ankara, Turkey), K. Hekimoglu (Ankara, Turkey), M. Cerit (Ankara, Turkey), G. Erbas (Ankara, Turkey), S. Özger (Ankara, Turkey), G. Bozdayi (Ankara, Turkey), E. Senol (Ankara, Turkey), A. Yurdakul (Ankara, Turkey), A. Yilmaz (Ankara, Turkey)
| |
Association between age, deprivation and ethnicity with COVID-19 hospitalisation and mortality
D. Jajbhay (London, United Kingdom), Y. Ong (London, United Kingdom), J. Gates (London, United Kingdom), M. Cusinato (London, United Kingdom), E. Lombard (London, United Kingdom), J. May (London, United Kingdom), A. Draper (London, United Kingdom)
| |
COVID-19 pneumonia and clinical follow-up: results of a prospective cohort
E. Vallejos (Ciudad Autónoma Buenos Aires, Argentina), S. Resnik (Ciudad Autónoma Buenos Aires, Argentina), F. Santtia (Ciudad Autónoma Buenos Aires, Argentina), L. Barria (Ciudad Autónoma Buenos Aires, Argentina), F. Felder (Ciudad Autónoma Buenos Aires, Argentina), M. Sosa (Ciudad Autónoma Buenos Aires, Argentina), F. Nogueira (Ciudad Autónoma Buenos Aires, Argentina), J. Enghelmayer (Ciudad Autónoma Buenos Aires, Argentina), A. Putruele (Ciudad Autónoma Buenos Aires, Argentina), C. Luna (Ciudad Autónoma Buenos Aires, Argentina)
| |
Predictors of worse prognosis in young adults hospitalized with COVID-19 pneumonia: a multi-center Italian study (COVID-UNDER50)
M. Bonifazi (Ancona (AN), Italy), F. Mei (Ancona (AN), Italy), E. Skrami (Ancona (AN), Italy), F. Carle (Ancona (AN), Italy), S. Gasparini (Ancona (AN), Italy), L. Zuccatosta (Ancona (AN), Italy), A. Di Marco Berardino (Ancona (AN), Italy), D. Amico (Pesaro, Italy), E. Balestro (padova, Italy), F. Bini (Garbagnate Milanese, Italy), P. Candoli (Bologna, Italy), A. Caminati (Milano , Italy), S. Harari (Milano , Italy), G. Marchetti (Brescia , Italy), G. Levi (Brescia , Italy), S. Piciucchi (Forli, Italy), V. Poletti (Forli, Italy), C. Ravaglia (Forli, Italy), S. Lococo (padova, Italy), M. Saetta (padova, Italy), S. Tomassetti (Firenze, Italy), M. Tamburrini (Pordenone, Italy), U. Zuccon (Pordenone, Italy), A. Zanforlin (Bolzano, Italy), V. Menditto (Ancona, Italy)
| |
Predictive factors of response to systemic corticosteroids in patients hospitalized with COVID-19 pneumoniae
I. Veiga Teijeiro (Lugo, Spain), I. Guzmán Peralta (Lugo, Spain), D. Pérez Ortiz (Lugo, Spain), L. Pérez De Llano (Lugo, Spain), I. Martín Robles (Lugo, Spain), N. Blanco Cid (Lugo, Spain), D. Dacal Rivas (Lugo, Spain), R. Golpe Gómez (Lugo, Spain)
| |
Association between type of antihyperglycemic therapy and COVID-19 outcomes in patients with type 2 DM
L. Akulkina (Moscow, Russian Federation), A. Schepalina (Moscow, Russian Federation), V. Sholomova (Moscow, Russian Federation), M. Brovko (Moscow, Russian Federation), S. Moiseev (Moscow, Russian Federation), A. Yanakaewa (Moscow, Russian Federation), D. Konovalov (Moscow, Russian Federation)
| |
Severity, risk of progression or thrombosis – what does the D-dimer really reflect in COVID-19 pneumonia?
M. Krykhtina (Dnipro, Ukraine), K. Bielosludtseva (Dnipro, Ukraine), T. Pertseva (Dnipro, Ukraine), L. Konopkina (Dnipro, Ukraine)
| |
Study of likelihood of infection with Covid-19 among hospital staff.
J. T.Kutty (Navi Mumbai (Maharashtra), India), B. Madhav (Navi Mumbai(Maharashtra), India), C. Prakash (Navi Mumbai(Maharashtra), India), D. Dhanwante (Navi Mumbai(Maharashtra), India), N. Patil (Navi Mumbai(Maharashtra), India), D. Revande (Navi Mumbai(Maharashtra), India)
| |
Severity or risk of progression: what does serum ferritin really reflect in COVID-19 pneumonia?
O. Myronenko (Dnipro, Ukraine), K. Bielosludtseva (Dnipro, Ukraine), L. Konopkina (Dnipro, Ukraine), T. Pertseva (Dnipro, Ukraine), O. Plekhanova (Dnipro, Ukraine), M. Krykhtina (Dnipro, Ukraine)
| |
Input of comorbidities to hospitalization of patients with COVID-19.
I. Lizinfeld (Moscow, Russian Federation), N. Pshenichnaya (Moscow, Russian Federation), L. Parolina (Moscow, Russian Federation), G. Zhuravlev (Moscow, Russian Federation)
| |
Evaluation of the relationship between laboratory parameters and pulmonary function tests in COVID-19 patients
B. Kerget (Erzurum, Turkey), A. Aksakal (Erzurum, Turkey), F. Kerget (Erzurum, Turkey)
| |
Early profiling of low-risk SARS-CoV-2 pneumonia for ward allocation
R. Méndez (Valencia, Spain), P. González-Jiménez (Valencia, Spain), A. Latorre (Valencia, Spain), L. Serrano (Barakaldo, Spain), L. Ruiz (Barakaldo, Spain), R. Zalacaín (Barakaldo, Spain), P. España (Galdakao, Spain), A. Uranga (Galdakao, Spain), C. Cillóniz (Barcelona, Spain), A. Torres (Barcelona, Spain), R. Menéndez (Valencia, Spain)
| |
Incidence and risk factors for structural lung disease following SARS-CoV-2 infection
A. Lehmann (Vienna, Austria), M. Gysan (Vienna, Austria), D. Bernitzky (Vienna, Austria), H. Prosch (Vienna, Austria), M. Idzko (Vienna, Austria), D. Gompelmann (Vienna, Austria)
| |
Mortality predictions of CURB-65, GPS and CALL scores in hospitalized patients with COVID-19
G. Karadeniz (Izmir, Turkey), F. Kazankaya (Izmir, Turkey), M. Buyuksiirin (Izmir, Turkey), M. Gayaf (Izmir, Turkey), F. Guldaval (Izmir, Turkey), F. Demirci Ucsular (Izmir, Turkey), C. Anar (Izmir, Turkey), G. Polat (Izmir, Turkey), Ö. Batum (Izmir, Turkey), A. Ayranci (Izmir, Turkey), E. Yalniz (Izmir, Turkey)
| |
Usefulness of CURB-65, PSI and MuLBSTA in predicting COVID-19 mortality
C. Preti (Bergamo, Italy), R. Biza (Bergamo, Italy), L. Novelli (Bergamo, Italy), A. Ghirardi (Bergamo, Italy), C. Conti (Bergamo, Italy), C. Galimberti (Milan, Italy), L. Della Bella (Bergamo, Italy), I. Memaj (Bergamo, Italy), I. Oppedisano (Bergamo, Italy), F. Zanardi (Bergamo, Italy), F. Di Marco (Bergamo, Italy), R. Cosentini (Bergamo, Italy)
| |
Covid-19 and gender: lower rate, but same mortality of severe disease in women
F. Raimondi (Bergamo, Italy), L. Novelli (Bergamo, Italy), A. Ghirardi (Bergamo, Italy), F. Russo (Bergamo, Italy), D. Pellegrini (Bergamo, Italy), R. Civiletti (Crema, Italy), L. Giuliani (Crema, Italy), R. Biza (Bergamo, Italy), C. Allegri (Bergamo, Italy), M. Anelli (Bergamo, Italy), R. Trapasso (Bergamo, Italy), M. Amoroso (Bergamo, Italy), L. Gandini (Bergamo, Italy), S. Comandini (Verona, Italy), C. Conti (Bergamo, Italy), C. Sanfilippo (Milan, Italy), G. Imeri (Bergamo, Italy), G. Marchesi (Bergamo, Italy), F. Lorini (Bergamo, Italy), F. Di Marco (Bergamo, Italy)
| |
preditive factors of severe outcome in patients with covid-19 pneumonia
B. Donia (Marsa, Tunisia), M. Maalej (Marsa, Tunisia), H. Blibech (Marsa, Tunisia), H. Snene (Marsa, Tunisia), A. Jbali (Marsa, Tunisia), I. Wadhane (Marsa, Tunisia), L. Kaabi (Marsa, Tunisia), A. Laater (Marsa, Tunisia), N. Mehiri (Marsa, Tunisia), N. Ben Salah (Marsa, Tunisia), B. Louzir (Marsa, Tunisia)
| |
Prognostic usefulness of severity scales for the initial assessment of elderly people with a diagnosis of pneumonia due to COVID-19. Design of a multivariate predictive model of mortality.
C. Urbina Carrera (Valladolid, Spain), R. López-Izquierdo (Valladolid, Spain), T. Ruiz Albi (Valladolid, Spain), J. Bermejo-Martín (Madrid, Spain), R. Almansa (Madrid, Spain), F. Villafañe Sanz (Valladolid, Spain), L. Arroyo Olmedo (Valladolid, Spain), S. Sánchez Ramón (Valladolid, Spain), F. Martín-Rodríguez (Valladolid, Spain), F. Moreno Torrero (Valladolid, Spain), D. Álvarez (Valladolid, Spain), F. Del Campo Matía (Valladolid, Spain)
| |